AI MARKET SCANNING

Inhibrx Biosciences Inc

📅 Next Catalyst: Nov 13, 2026 (🌙 Close) 🏛️ NASDAQ 📁 Health Technology 🏭 Biotechnology
AVG HISTORICAL GAP -1.05%
MAX GAP RECORD -2.94%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $INBX
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Nov 13, 2026 Earnings Release 2026-11-13 (UNDETERMINED) 🔮 UPCOMING 🔒
Aug 19, 2026 Earnings Release 2026-08-19 (AFTER CLOSE)
-2.79%
May 13, 2026 Earnings Release 2026-05-13 (AFTER CLOSE)
+0.00%
Mar 19, 2026 Earnings Release 2026-03-19 (AFTER CLOSE)
-1.51%
Nov 14, 2025 Earnings Release 2025-11-14 (BEFORE OPEN)
-2.31%
Aug 13, 2025 Earnings Release 2025-08-13 (AFTER CLOSE)
+2.04%
May 14, 2025 Earnings Release 2025-05-14 (AFTER CLOSE)
+1.20%
Mar 17, 2025 Earnings Release 2025-03-17 (AFTER CLOSE)
-2.94%

VOLATILITY & GAP BIAS

AVG GAP MOVE 2.1%
Bullish Gaps (2)
Bearish Gaps (4)
Neutral / Flat (0)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $INBX

EXECUTIONS1 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
2026-08-13 🔒 PRO RADAR ••• x• $•••.•• → $•••.•• 1068m +7.33%
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

Inhibrx Biosciences, Inc. is a clinical-stage biopharmaceutical company, which includes a pipeline of novel biologic therapeutic candidates, developed using proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize multivalent formats where the precise valency can be optimized in a target-centric…

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗